| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 06/16/2011 | WO2011047265A4 Resonance energy transfer assay with synaptobrevin substrate moiety |
| 06/16/2011 | WO2006012440A8 Preparation of alkyl-substituted 2-deoxy-2-fluoro-d-ribofuranosyl pyrimidines and purines and their derivatives |
| 06/16/2011 | US20110145953 Marker mapping and resistance gene associations in soybean |
| 06/16/2011 | US20110145951 Transgenic sweet sorghum with altered lignin composition and process of preparation thereof |
| 06/16/2011 | US20110145949 Plants Having Enhanced Yield-Related Traits and a Method for Making the Same |
| 06/16/2011 | US20110145948 Transgenic Plants Comprising as Transgene a Phosphatidate Cytidylyltransferase |
| 06/16/2011 | US20110145944 Brassica plant comprising mutant fatty acyl-acp thioesterase alleles |
| 06/16/2011 | US20110145941 Antibodies and derivatives thereof |
| 06/16/2011 | US20110145940 Tal effector-mediated dna modification |
| 06/16/2011 | US20110144318 Selected nucleotide sequences isolated from pathogenic strains of haemophilus influenzae |
| 06/16/2011 | US20110144317 Mutants of glycoside hydrolases and uses thereof for synthesizing complex oligosaccharides and disaccharide intermediates |
| 06/16/2011 | US20110144313 Membrane fusion proteins derived from reovirus |
| 06/16/2011 | US20110144302 Polypeptide |
| 06/16/2011 | US20110144206 Use of a cox-2 inhibitor for the treatment of a cox-2 dependent disorder in a patient not carrying hla alleles associated with hepatotoxicity |
| 06/16/2011 | US20110144187 Aptamer inhibition of thrombus formation |
| 06/16/2011 | US20110144186 Ssx-2 peptides presented by hla class ii molecules |
| 06/16/2011 | US20110144185 Rna antagonists targeting hsp27 |
| 06/16/2011 | US20110144183 Oligonucleotides for treating inflammation and neoplastic cell proliferation |
| 06/16/2011 | US20110144182 Treatment of surgical adhesions |
| 06/16/2011 | US20110143966 Surface Modifications and Methods for their Synthesis and Use |
| 06/16/2011 | US20110143964 Fluidic devices and methods for multiplex chemical and biochemical reactions |
| 06/16/2011 | US20110143959 Compositions and methods for determining the prognosis of bladder urothelial cancer |
| 06/16/2011 | US20110143956 Diagnostic Kits and Methods for SCD or SCA Therapy Selection |
| 06/16/2011 | US20110143954 Gamma-secretase substrate and methods of use |
| 06/16/2011 | US20110143946 Method for predicting the response of a tumor in a patient suffering from or at risk of developing recurrent gynecologic cancer towards a chemotherapeutic agent |
| 06/16/2011 | US20110143436 Compositions and methods for reprogramming eukaryotic cells |
| 06/16/2011 | US20110143428 Anti-vegf-c antibodies and methods using same |
| 06/16/2011 | US20110143422 Recovery of recombinant human parainfluenza virus type 2 (hypiv2) from cdna and use of recombinant hpiv2 in immunogenic compositions and as vectors to elicit immune responses against piv and other human pathogens |
| 06/16/2011 | US20110143406 Novel (S,S) -Butanediol Dehydrogenase, Gene for the Same, and Use of the Same |
| 06/16/2011 | US20110143401 Devices to Extend Single Stranded Target Molecules |
| 06/16/2011 | US20110143400 Sirna and methods of manufacture |
| 06/16/2011 | US20110143399 Dna joining method |
| 06/16/2011 | US20110143395 Thermophilic and thermoacidophilic biopolymer-degrading genes and enzymes from alicyclobacillus acidocaldarius and related organisms, methods |
| 06/16/2011 | US20110143394 Methods and Means for Metabolic Engineering and Improved Product Formation by Micro-Organisms |
| 06/16/2011 | US20110143387 Highly water-soluble, cationic luminescent labels |
| 06/16/2011 | US20110143377 Protein fragments of virB10 and sero-detection of anaplasma phagocytophium |
| 06/16/2011 | US20110143370 Nucleic Acids Encoding a Mammalian Raptor Polypeptide and Uses Therefor |
| 06/16/2011 | US20110143360 Cancer marker, method for evaluation of cancer by using the cancer marker, and evaluation reagent |
| 06/16/2011 | US20110143350 Primers and methods for the detection and discrimination of nucleic acids |
| 06/16/2011 | US20110143346 Cotton event mon15985 and compositions and methods for detection thereof |
| 06/16/2011 | US20110143345 Genetic Markers for SCD or SCA Therapy Selection |
| 06/16/2011 | US20110143344 Genetic polymorphisms and substance dependence |
| 06/16/2011 | US20110143337 Unsymmetrical cyanine dimer compounds and their application |
| 06/16/2011 | US20110142921 NOVEL RNAi THERAPEUTIC FOR TREATMENT OF HEPATITIS C INFECTION |
| 06/16/2011 | US20110142918 Anti-angiogenic compositions and therapeutic applications thereof |
| 06/16/2011 | US20110142915 Compositions and methods for inhibition of vegf |
| 06/16/2011 | US20110142911 HIV epitopes and pharmaceutical composition containing same |
| 06/16/2011 | US20110142879 Infectious clones |
| 06/16/2011 | US20110142878 Polynucleotides allowing the expression and secretion of recombinant pseudo-virus containing foreign epitopes, their production, and use |
| 06/16/2011 | US20110142874 Compositions, Methods, and Kits for Eliciting an Immune Response |
| 06/16/2011 | US20110142871 Compounds and methods for diagnosis and immunotherapy of tuberculosis |
| 06/16/2011 | US20110142869 Membrane proximal region of hiv gp41 anchored to the lipid layer of a virus-like particle vaccine |
| 06/16/2011 | US20110142865 Tumor-associated Peptides Binding Promiscuously to Human Leukocyte Antigen (HLA) Class II Molecules |
| 06/16/2011 | US20110142864 Tumor-associated Peptides Binding Promiscuously to Human Leukocyte Antigen (HLA) Class II Molecules |
| 06/16/2011 | US20110142862 Transgenic mice having a human major histocompatibility complex (mhc) phenotype, experimental uses and applications |
| 06/16/2011 | US20110142852 Multispecific antibodies |
| 06/16/2011 | US20110142851 IL6 Immunotherapeutics |
| 06/16/2011 | US20110142847 Methods of Eliciting Broadly Neutralizing Antibodies Targeting HIV-1 GP41 |
| 06/16/2011 | US20110142845 NEUTRALIZING MONOCLONAL ANTIBODIES AGAINST THE NOGO-66 RECEPTOR (NgR) AND USES THEREOF |
| 06/16/2011 | US20110142841 Compositions and methods for the treatment of systemic lupus erythematosis |
| 06/16/2011 | US20110142825 Glycosylation Engineering of Antibodies for Improving Antibody-Dependent Cellular Cytotoxicity |
| 06/16/2011 | US20110142816 Thermostabilization of proteins |
| 06/16/2011 | US20110142791 Compositions and methods for prevention of escape mutation in the treatment of her2/neu over-expressing tumors |
| 06/16/2011 | CA2820315A1 Hyperprimers |
| 06/16/2011 | CA2781896A1 Modulation of hsp47 expression |
| 06/16/2011 | CA2781883A1 Anti-microbial agent from paenibacillus sp. and methods and uses thereof |
| 06/15/2011 | EP2333118A1 Method for rapid detection and identification of bioagents |
| 06/15/2011 | EP2333113A1 Dark quenchers for donor-acceptor energy transfer |
| 06/15/2011 | EP2333099A2 Enzymes having alpha amylase activity and methods of use thereof |
| 06/15/2011 | EP2333098A2 Enzymes having alpha amylase activity and methods of use thereof |
| 06/15/2011 | EP2333097A2 Enzymes having alpha amylase activity and methods of use thereof |
| 06/15/2011 | EP2333079A1 Chimeric promoters for use in plants |
| 06/15/2011 | EP2332972A1 Novel Beta-Actin and RPS21 promoters and uses thereof |
| 06/15/2011 | EP2332958A1 Detection of nucleic and sequence differences using the ligase detection reaction with addressable arrays |
| 06/15/2011 | EP2332957A1 Detection of nucleic and acid sequence differences using the ligase detection reaction with addressable arrays |
| 06/15/2011 | EP2332956A1 Antibody binding to PRO71238 |
| 06/15/2011 | EP2332955A2 Antisense modulation of acyl CoA cholesterol acyltransferase-2 expression |
| 06/15/2011 | EP2332954A2 Process for the preparation of phosphorothionate oligonucleotides |
| 06/15/2011 | EP2332951A2 6-modified bicyclic nucleic acid analogs |
| 06/15/2011 | EP2332645A1 Apparatus for chemical and biochemical reactions using photo-generated reagents |
| 06/15/2011 | EP2331566A1 Method and compositions for enhanced anti-tumor effector functioning of t cells |
| 06/15/2011 | EP2331558A2 Protected monomers and methods of deprotection for rna synthesis |
| 06/15/2011 | EP2331557A1 Alphavirus packaging cell lines |
| 06/15/2011 | EP2331105A2 Modulation of toll-like receptor 7 expression by antisense oligonucleotides |
| 06/15/2011 | EP1766093B1 Antibodies against clostridium difficile toxins and uses thereof |
| 06/15/2011 | EP1481061B1 Denaturant stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same and their uses |
| 06/15/2011 | EP1282722B1 Stabilized proteins |
| 06/15/2011 | EP1012274B2 Death domain containing receptor 4 (dr4: death receptor 4), member of the tnf-receptor superfamily and binding to trail (ap0-2l) |
| 06/15/2011 | CN1974591B SiRNA expression template for treating liver necrosis and liver fibrosis |
| 06/15/2011 | CN1950392B Lactobacillus acidophilus nucleic acid sequences encoding carbohydrate utilization-related proteins and uses therefor |
| 06/15/2011 | CN1865275B Artificial single-chain deoxynucleotide having therapeutic effect to human B cell tumour |
| 06/15/2011 | CN1847256B Antiviral prepn containing both CpG single-strand deoxyoligonucleotide and ribavirin |
| 06/15/2011 | CN1452656B Lipoxygenase |
| 06/15/2011 | CN102099476A Compositions and methods for improving plants |
| 06/15/2011 | CN102099474A Oligonucleotides for treating inflammation and neoplastic cell proliferation |
| 06/15/2011 | CN102099467A SiRNA of human osteopontin |
| 06/15/2011 | CN101613697B Method for extracting and purifying DNA |
| 06/15/2011 | CN101130770B Nucleotide molecule SR2B and application of the same in producing antidiabetic medicament |
| 06/15/2011 | CN101130769B Nucleotide molecule SR4B and application of the same in producing antidiabetic medicament |
| 06/14/2011 | US7960609 Plant vector pBSNB-TEV, vectors derived therefrom, and methods of use |